| Literature DB >> 27187451 |
Paul J Arciero1, Rohan C Edmonds2, Kanokwan Bunsawat3, Christopher L Gentile4, Caitlin Ketcham5, Christopher Darin6, Mariale Renna7, Qian Zheng8, Jun Zhu Zhang9, Michael J Ormsbee10,11.
Abstract
We recently reported that protein-pacing (P; six meals/day @ 1.4 g/kg body weight (BW), three of which included whey protein (WP) supplementation) combined with a multi-mode fitness program consisting of resistance, interval sprint, stretching, and endurance exercise training (RISE) improves body composition in overweight individuals. The purpose of this study was to extend these findings and determine whether protein-pacing with only food protein (FP) is comparable to WP supplementation during RISE training on physical performance outcomes in overweight/obese individuals. Thirty weight-matched volunteers were prescribed RISE training and a P diet derived from either whey protein supplementation (WP, n = 15) or food protein sources (FP, n = 15) for 16 weeks. Twenty-one participants completed the intervention (WP, n = 9; FP, n = 12). Measures of body composition and physical performance were significantly improved in both groups (p < 0.05), with no effect of protein source. Likewise, markers of cardiometabolic disease risk (e.g., LDL (low-density lipoprotein) cholesterol, glucose, insulin, adiponectin, systolic blood pressure) were significantly improved (p < 0.05) to a similar extent in both groups. These results demonstrate that both whey protein and food protein sources combined with multimodal RISE training are equally effective at improving physical performance and cardiometabolic health in obese individuals.Entities:
Keywords: PRISE exercise training; cardiometabolic-risk; physical performance; protein-pacing
Mesh:
Substances:
Year: 2016 PMID: 27187451 PMCID: PMC4882701 DOI: 10.3390/nu8050288
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1CONSORT (Consolidated Standards of Reporting Trials) flow chart of participants during the study intervention.
Participant Characteristics.
| Variable | WP | FP |
|---|---|---|
| Sex (M/F) | 4/5 | 7/5 |
| Age (year) | 48 ± 4 | 52 ± 1 |
| Height (cm) | 173 ± 3 | 172 ± 3 |
| Weight (kg) | 96 ± 3 | 97 ± 5 |
| Body mass index | 32 ± 2 | 33 ± 1 |
WP: whey protein; FP: food protein. All values are means ± SE.
Figure 2Comparisons of physical performance assessments between the food protein (FP) and the whey protein (WP) groups following the protein-pacing, resistance, interval, stretching, endurance training (PRISE): upper (A) and lower body maximal strength (B); core (C) and upper body muscular endurance (D); balance (E); flexibility (F) and grip strength (G). a Significantly different from baseline in each group (p < 0.01).
Body composition measures at baseline and post-intervention.
| Variable | WP | FP | ||||
|---|---|---|---|---|---|---|
| Pre | Post | Δ % | Pre | Post | Δ % | |
| Body Mass (kg) | 95.8 ± 6.1 | 90.9 ± 5.5 a | −4.8 ± 1.2 | 96.9 ± 4.8 | 92.2 ± 4.4 a | −4.8 ± 0.9 |
| Waist (cm) | 105.2 ± 3.7 | 94.3 ± 3.0 a | −10.1 ± 1.9 | 104.7 ± 3.1 | 96.3 ± 3.2 a | −7.9 ± 1.3 |
| Fat Mass (kg) | 35.8 ± 2.9 | 31.7 ± 2.6 a | −10.9 ± 2.3 | 38.4 ± 2.8 | 34.1 ± 2.8 a | −11.9 ± 1.8 |
| % Fat Mass | 38.8 ± 1.9 | 36.2 ± 1.8 a | −6.8 ± 1.6 | 41.4 ± 2.4 | 38.5 ± 2.6 a | −7.5 ± 1.2 |
| AbFat Mass (kg) | 5.1 ± 0.4 | 4.2 ± 0.3 a | −15.3 ± 4.7 | 5.5 ± 0.4 | 4.7 ± 0.4 a | −15.9 ± 2.8 |
| VAT (g) | 1232.6 ± 219.9 | 884. 9 ± 173.3 a | −29.9 ± 5.6 | 1816.8 ± 262.2 | 1498.2 ± 221.9 a | −18.1 ± 4.8 |
Data presented as means ± SE. Pre, baseline; AbFat, abdominal fat; VAT, visceral adipose tissue. a Significantly different from baseline (p < 0.05).
Figure 3Comparison of percent lean body mass percent (%) lean body mass between the food protein (FP) and the whey protein (WP) groups following the PRISE training. a Significantly different from baseline in each group (p < 0.01).
Cardiometabolic markers at baseline and post-intervention.
| Variable | WP | FP | ||
|---|---|---|---|---|
| Pre | Post | Pre | Post | |
| HR (beats/min) | 63.3 ± 4.0 | 61.1 ± 2.1 | 64.8 ± 2.8 | 61.0 ± 2.3 |
| SBP (mmHg) | 130.4 ± 5.0 | 116.0 ± 4.1 a | 124.3 ± 3.3 | 119.2 ± 2.9 a |
| DBP (mmHg) | 83.6 ± 2.7 | 80.3 ± 2.3 | 84.8 ± 2.4 | 84.0 ± 2.1 |
| TGL (mg/dL) | 171.8 ± 29.8 | 123.2 ± 27.0 a | 94.2 ± 8.5 * | 104.4 ± 12.8 # |
| Cholesterol (mg/dL) | 192.2 ± 20.0 | 151.3 ± 10.9 a | 197.8 ± 8.3 | 166.3 ± 5.0 a |
| HDL (mg/dL) | 42. 6 ± 4.0 | 46.1 ± 4.6 | 52.8 ± 4.6 * | 50.0 ± 4.7 # |
| LDL (mg/dL) | 115. 2 ± 20.1 | 92.0 ± 9.6 a | 126.2 ±7.8 | 98.9 ± 5.1 a |
| GLU (mg/dL) | 97. 0 ± 4.6 | 93.6 ± 4.2 a | 104.0 ± 3.0 | 94.1 ± 2.0 a |
| Insulin (μg/dL) | 21.7 ± 10.5 | 7.5 ± 2.0 a | 9.6 ± 2.3 * | 7.7 ± 2.0 a |
| HOMA-IR (units) | 1.0 ± 0.3 | 1.0 ± 0.3 | 0.9 ± 0.2 | 1.2 ± 0.3 |
| LEP (ng/dL) | 26.0 ± 4.2 | 18.7 ± 1.9 a | 42.4 ± 10.5 * | 29.8 ± 9.3 a |
| ADI (μg/dL) | 18.5 ± 1.5 | 21.1 ± 1.5 a | 19.2 ± 1.6 | 23.5 ± 2.4 a |
Data presented as means ± SE. Pre, baseline; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; TGL, plasma triglycerides; GLU, fasting plasma glucose; Insulin, fasting plasma insulin; HOMA-IR, homeostasis model assessment-estimated insulin resistance; LEP, leptin; ADI, adiponectin. a Significantly different from baseline (p < 0.05); * significantly different from WP at baseline (<0.05); # significantly different from WP post-intervention (<0.05).
Dietary intake and hunger ratings at baseline and post-intervention.
| Variable | WP | FP | ||
|---|---|---|---|---|
| Pre | Post | Pre | Post | |
| Kcal | 2146 ± 175 | 1889 ± 148 a | 2094 ± 194 | 1833 ± 158 a |
| Protein (g) | 92 ± 10 | 150 ± 14 a | 94 ± 7 | 140 ± 8 a |
| Protein (%) | 17 ± 2 | 33 ± 2 a | 20 ± 1 | 30 ± 2 a |
| Protein (g/kg) | 1.0 ± 0.12 | 1.7 ± 0.17 a | 0.9 ± 0.1 | 1.6 ± 0.2 a |
| Carbohydrates (g) | 253 ± 20 | 178 ± 19 a | 214 ± 17 | 158 ± 16 a |
| Carbohydrates (%) | 48 ± 2 | 38 ± 2 a | 43 ± 2 | 34 ± 2 a |
| Fat (g) | 77 ± 9 | 62 ± 4 | 75 ± 9 | 76 ± 12 |
| Fat (%) | 33 ± 2 | 30 ± 1 | 33 ± 2 | 36 ± 3 |
| Fiber (g) | 14 ± 1 | 26 ± 3 | 22 ± 3 | 23 ± 4 |
| Omega 3 | 2 ± 0.5 | 2 ± 1 | 1 ± 0.1 | 2 ± 0.5 |
| Hunger | 36 ± 8 | 31 ± 7 a | 46 ± 6 | 30 ± 8 a |
| Satiety | 23 ± 7 | 44 ± 5 a | 37 ± 6 | 44 ± 11 a |
| Desire to eat | 39 ± 10 | 38 ± 7 | 48 ± 6 | 31 ± 6 a |
Data presented as means ± SE. Pre, baseline; Post, post-intervention. a Significantly different from baseline (p < 0.05).